What is Anti-D Rho(D) Immune Globulin (RhoGAM)?
Anti-D Rho(D) Immune Globulin, widely known by the brand name RhoGAM, is a sterile, injectable medication derived from human plasma. It contains antibodies to the Rho(D) antigen of human red blood cells. In Nigeria, this injection is a critical component of prenatal and postpartum care for women with Rhesus-negative blood types.
Primary Uses and Indications
The Rhogam injection is primarily used to prevent Rhesus (Rh) isoimmunization (also called sensitization). This occurs when an Rh-negative person is exposed to Rh-positive blood, causing their immune system to produce antibodies.
The most common scenarios for administration include:
- During Pregnancy: Typically given around the 28th week of pregnancy to Rh-negative women.
- Post-Delivery: Administered within 72 hours of delivering an Rh-positive baby.
- Medical Interventions: Used after miscarriages, ectopic pregnancies, or abdominal trauma during pregnancy.
- Blood Transfusions: To treat Rh-negative individuals who have received Rh-positive blood.
How Does It Work?
Rhogam works by "hiding" any Rh-positive red blood cells that may have entered the mother's bloodstream from the fetus. By doing this, it prevents the mother's immune system from recognizing these cells and producing its own antibodies, which could otherwise attack the red blood cells of a fetus in a future pregnancy (Hemolytic Disease of the Fetus and Newborn).
Dosage and Administration
The standard dose for full-term prophylaxis is 300 mcg (1500 IU). It is important to note that while sometimes mistakenly referred to as "300mg," the correct therapeutic dose is 300 micrograms.
This medication must be administered by a healthcare professional via intramuscular (IM) injection. It is a cold-chain product and must be stored between 2°C and 8°C.
Safety and Consultation
Anti-D Rhogam is a Prescription-Only Medicine (POM). If you have questions about your Rhesus status or need to arrange for this medication, you can contact a GoMed pharmacist for professional guidance.
Note: Always ensure the injection is administered in a clinical setting where your medical history can be reviewed.